These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 15572731

  • 21. Over-expression of Smac promotes TRAIL-induced cell death in human hepatocellular carcinoma.
    Okano H, Shiraki K, Inoue H, Kawakita T, Saitou Y, Enokimura N, Yamamoto N, Sugimoto K, Fujikawa K, Murata K, Nakano T.
    Int J Mol Med; 2003 Jul; 12(1):25-8. PubMed ID: 12792804
    [Abstract] [Full Text] [Related]

  • 22. Role of Smac/DIABLO in cancer progression.
    Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, Grajeda JP, Melendez-Zajgla J.
    J Exp Clin Cancer Res; 2008 Sep 26; 27(1):48. PubMed ID: 18822137
    [Abstract] [Full Text] [Related]

  • 23. Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas.
    Shibata T, Noguchi T, Takeno S, Gabbert HE, Ramp U, Kawahara K.
    Ann Surg Oncol; 2008 Dec 26; 15(12):3579-87. PubMed ID: 18807090
    [Abstract] [Full Text] [Related]

  • 24. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
    Checinska A, Hoogeland BS, Rodriguez JA, Giaccone G, Kruyt FA.
    Exp Cell Res; 2007 Apr 01; 313(6):1215-24. PubMed ID: 17291493
    [Abstract] [Full Text] [Related]

  • 25. Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy.
    Mizutani Y, Katsuoka Y, Bonavida B.
    Int J Oncol; 2010 Aug 01; 37(2):503-8. PubMed ID: 20596678
    [Abstract] [Full Text] [Related]

  • 26. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
    Bilim V, Kawasaki T, Katagiri A, Wakatsuki S, Takahashi K, Tomita Y.
    Clin Cancer Res; 2000 Feb 01; 6(2):460-6. PubMed ID: 10690524
    [Abstract] [Full Text] [Related]

  • 27. Interaction between XIAP and Smac/DIABLO in the mouse brain after transient focal cerebral ischemia.
    Saito A, Hayashi T, Okuno S, Ferrand-Drake M, Chan PH.
    J Cereb Blood Flow Metab; 2003 Sep 01; 23(9):1010-9. PubMed ID: 12973017
    [Abstract] [Full Text] [Related]

  • 28. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
    Petrucci E, Pasquini L, Petronelli A, Saulle E, Mariani G, Riccioni R, Biffoni M, Ferretti G, Benedetti-Panici P, Cognetti F, Scambia G, Humphreys R, Peschle C, Testa U.
    Gynecol Oncol; 2007 May 01; 105(2):481-92. PubMed ID: 17292950
    [Abstract] [Full Text] [Related]

  • 29. Immunoexpression of inhibitors of apoptosis proteins and their antagonist SMAC/DIABLO in colorectal carcinoma: correlation with apoptotic index, cellular proliferation and prognosis.
    De Oliveira Lima F, De Oliveira Costa H, Barrezueta LF, Fujiyama Oshima CT, Silva JA, Gomes TS, Pinheiro N, Neto RA, Franco M.
    Oncol Rep; 2009 Aug 01; 22(2):295-303. PubMed ID: 19578769
    [Abstract] [Full Text] [Related]

  • 30. Kinetics of Smac/DIABLO release from mitochondria during apoptosis of MCF-7 breast cancer cells.
    Gorka M, Godlewski MM, Gajkowska B, Wojewodzka U, Motyl T.
    Cell Biol Int; 2004 Aug 01; 28(11):741-54. PubMed ID: 15563396
    [Abstract] [Full Text] [Related]

  • 31. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
    Kempkensteffen C, Hinz S, Christoph F, Krause H, Magheli A, Schrader M, Schostak M, Miller K, Weikert S.
    J Cancer Res Clin Oncol; 2008 May 01; 134(5):543-50. PubMed ID: 17922292
    [Abstract] [Full Text] [Related]

  • 32. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ, Wang ZP, Rodriguez R, Fu JS, Lu JZ, Ma BL.
    Urology; 2006 May 01; 67(5):1093-8. PubMed ID: 16635513
    [Abstract] [Full Text] [Related]

  • 33. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.
    Clin Cancer Res; 2007 Dec 15; 13(24):7388-93. PubMed ID: 18094421
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Nuclear expression of cIAP-1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas.
    Tanimoto T, Tsuda H, Imazeki N, Ohno Y, Imoto I, Inazawa J, Matsubara O.
    Cancer Lett; 2005 Jun 16; 224(1):141-51. PubMed ID: 15911110
    [Abstract] [Full Text] [Related]

  • 39. Role of Smac in human leukaemic cell apoptosis and proliferation.
    Jia L, Patwari Y, Kelsey SM, Srinivasula SM, Agrawal SG, Alnemri ES, Newland AC.
    Oncogene; 2003 Mar 20; 22(11):1589-99. PubMed ID: 12642862
    [Abstract] [Full Text] [Related]

  • 40. Apoptosis induced by cAMP requires Smac/DIABLO transcriptional upregulation.
    Martinez-Velazquez M, Melendez-Zajgla J, Maldonado V.
    Cell Signal; 2007 Jun 20; 19(6):1212-20. PubMed ID: 17320350
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.